Sleep Loss and Insulin Resistance Study

This study is looking at how sleep loss affects insulin resistance (when your body's cells don't respond well to insulin, a hormone that helps control blood sugar). Researchers want to understand if changing cortisol (a stress hormone) levels can prevent insulin resistance caused by not getting enough sleep. You might receive Metyrapone and Hydrocortisone to control your cortisol levels, and Dextrose and insulin as part of a test to measure your body's response to sugar. The study aims to see if these interventions change your insulin resistance, measured by specific tests. They are looking for 48 healthy men and women between 18 and 45 years old with a stable weight. The current status of recruitment is unclear.

Study design
This is an interventional study planning to enroll 48 participants. The study involves giving participants specific medications to understand their effects.
What's involved
Not specified in the trial record.
Compensation
Not stated in the trial record.
Follow-up
Insulin resistance will be measured at change from baseline collection, but the duration of follow-up is not specified.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.

NCT07494084

Sleep Loss and Circadian Misalignment - Mechanisms of Insulin Resistance

Not Yet Recruiting
PHASE4Ages 18–45InterventionalDiagnostic
Washington State University
~48 participants
Updated 2026-05-15 on ClinicalTrials.gov
What's tested:Metyrapone And HydrocortisoneDextroseinsulin

At a glance

Recruiting sites
0 of 1 listed site is recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Insulin resistance-Minimal Model (Si)
Measured over Change from baseline collection.
+2 more outcomes measured
Shift Work Schedule
Circadian Rhythm
Insulin Resistance
Circadian Misalignment
1 sites across 1 states
Washington1
  • Peter Liu, MBBS, PhD · PRINCIPAL_INVESTIGATOR · Lundquist Institute of Biomedical Innovation at Harbor-UCLA Medical Center
  • Hans P.A. Van Dongen, PhD · PRINCIPAL_INVESTIGATOR · Washington State University

Opens a ready-to-send draft in your own email app — review before sending.

  • Insulin resistance-Minimal Model (Si)Change from baseline collection.

    Insulin resistance-minimal model (Si) will be measured from the frequently sampled intravenous glucose tolerance test (FSIVGTT) and reflects glucose disposal rate during the insulin response. it will be calculated as the change from baseline (by subtraction).

  • Insulin Resistance-Homeostatic Model Assessment of Insulin Resistance (HOMA-IR)Change from baseline collection.

    The Homeostatic Model Assessment of Insulin Resistance (HOMA-IR) will be measured from the frequently samples intravenous glucose tolerance test (FSIVGTT) and reflects the fasting insulin resistance. It will be calculated as the change from baseline (by subtraction).

  • Insulin Resistance-Insulin Sensitivity Index (Mi)Change from baseline collection.

    The Insulin Sensitivity Index (Mi) will be measured from the frequently sampled intravenous glucose tolerance test (FSIVGTT). Si is calculated using the minimal model and measures whole-body insulin sensitivity. It will be calculated as the change from baseline (by subtraction).